EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C27H37N9O7S3 |
| Net Charge | 0 |
| Average Mass | 695.850 |
| Monoisotopic Mass | 695.19781 |
| SMILES | [H][C@]12SCC(CSc3nnnn3CCN(C)C)=C(C(=O)OC(C)OC(=O)OC3CCCCC3)N1C(=O)[C@@]2([H])NC(=O)Cc1csc(N)n1 |
| InChI | InChI=1S/C27H37N9O7S3/c1-15(42-27(40)43-18-7-5-4-6-8-18)41-24(39)21-16(13-46-26-31-32-33-35(26)10-9-34(2)3)12-44-23-20(22(38)36(21)23)30-19(37)11-17-14-45-25(28)29-17/h14-15,18,20,23H,4-13H2,1-3H3,(H2,28,29)(H,30,37)/t15?,20-,23-/m1/s1 |
| InChIKey | VVFDMWZLBPUKTD-ZKRNHDOASA-N |
| Roles Classification |
|---|
| Application: | prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| cefotiam hexetil ester (CHEBI:59211) has functional parent cefotiam (CHEBI:355510) |
| cefotiam hexetil ester (CHEBI:59211) has role prodrug (CHEBI:50266) |
| cefotiam hexetil ester (CHEBI:59211) is a carboxylic ester (CHEBI:33308) |
| Incoming Relation(s) |
| cefotiam hexetil dihydrochloride (CHEBI:31373) has part cefotiam hexetil ester (CHEBI:59211) |
| IUPAC Names |
|---|
| 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 7β-(2-amino-1,3-thiazol-4-yl)acetamido-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-3,4-didehydrocepham-4-carboxylate |
| Synonyms | Source |
|---|---|
| cefotiam 1-(cyclohexyloxycarbonyloxy)ethyl ester | ChEBI |
| cefotiam hexetil | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| 549 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:95761-91-4 | ChemIDplus |